Estreba, Teresita B.

HRN: 28-85-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/13/2026
04/19/2026
IV
600MG
Q8H
DM FOOT
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: